Targeted Clinical Research Program to Address Selected Viral Infections

Abstract

To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy. This study is conducted in adult transplant patients and includes a Phase II clinical trial.

Key facts

NIH application ID

11041790

Project number

272201600015C-P00013-9999-1

Recipient

FRED HUTCHINSON CANCER CENTER

Principal Investigator

MICHAEL BOECKH

Activity code

N01

Funding institute

NIH

Fiscal year

2024

Award amount

$237,480

Award type

—

Project period

2016-07-01 → 2025-01-02